Montag A & Associates Inc Aerie Pharmaceuticals Inc Transaction History

Montag A & Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$6.37 - $15.23 $318 - $761	-50 Reduced 1.45%	3,408 $52,000
Q2 2022 Aug 10, 2022	SELL	$4.95 - $9.16 $14,107 - $26,106	-2,850 Reduced 45.18%	3,458 $26,000
Q4 2021 Feb 09, 2022	SELL	$7.02 - $13.33 $9,828 - $18,662	-1,400 Reduced 18.16%	6,308 $44,000
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $70,296 - $111,688	7,708 New	7,708 $104,000
Q2 2020 Aug 04, 2020	SELL	$12.0 - $16.13 $122,496 - $164,655	-10,208 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$11.84 - $25.52 $102,451 - $220,824	-8,653 Reduced 45.88%	10,208 $138,000
Q4 2019 Feb 05, 2020	SELL	$17.72 - $25.1 $36,591 - $51,831	-2,065 Reduced 9.87%	18,861 $456,000
Q3 2019 Nov 04, 2019	SELL	$18.41 - $28.0 $2,761 - $4,200	-150 Reduced 0.71%	20,926 $402,000
Q2 2019 Aug 06, 2019	SELL	$28.97 - $48.21 $6,518 - $10,847	-225 Reduced 1.06%	21,076 $623,000
Q1 2019 May 01, 2019	SELL	$36.32 - $49.25 $278,647 - $377,846	-7,672 Reduced 26.48%	21,301 $1.01 Million
Q4 2018 Feb 06, 2019	SELL	$33.0 - $60.04 $309,111 - $562,394	-9,367 Reduced 24.43%	28,973 $1.05 Million
Q3 2018 Nov 07, 2018	BUY	$56.15 - $73.9 $2.15 Million - $2.83 Million	38,340 New	38,340 $2.36 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Montag A & Associates Inc with notifications on news.